Niles Investment Management founder Dan Niles expects the “Magnificent Seven” names to post a strong second quarter– but he’s not entirely convinced that the stocks will push meaningfully…
Pharmaceutical companies are seeking clarification on tariffs imposed under the new US-EU trade agreement. Analysts caution that sector-specific punitive levies could jeopardise the entire deal, according to a CNBC…
Niles Investment Management founder Dan Niles expects the “Magnificent Seven” names to post a strong second quarter– but he’s not entirely convinced that the stocks will push meaningfully…